Barry Fuller

512 A BARRIER BETWEEN BIOMASS AND PATIENT IN A BIOARTIFICIAL LIVER SYSTEM (BAL): MEETING REGULATORY REQUIREMENTS AND PROVIDING CLINICAL BENEFIT

C. Selden, A Gander, H. Humphrey, 2010 .

Role of Bioreactor Technology in Tissue Engineering for Clinical Use and Therapeutic Target Design

Clare Selden, Barry Fuller, C. Selden, 2018, Bioengineering.

Bioengineering the Liver: Scale-Up and Cool Chain Delivery of the Liver Cell Biomass for Clinical Targeting in a Bioartificial Liver Support System

Cécile Legallais, Mike Hoare, Humphrey Hodgson, 2013, BioResearch open access.

Evaluation of Encapsulated Liver Cell Spheroids in a Fluidised-Bed Bioartificial Liver for Treatment of Ischaemic Acute Liver Failure in Pigs in a Translational Setting

Humphrey Hodgson, Clare Selden, Delawir Kahn, 2013, PloS one.

A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure

Humphrey Hodgson, Peter Kilbride, Clare Selden, 2017, Scientific Reports.

Shear‐stress preconditioning and tissue‐engineering‐based paradigms for generating arterial substitutes

Alexander M Seifalian, David Murray, Mohamed Baguneid, 2004, Biotechnology and applied biochemistry.

Fundamentals of cryobiology in reproductive medicine.

Barry Fuller, B. Fuller, Sharon Paynter, 2004, Reproductive biomedicine online.